Tabid, Dan Aiza .

HRN: 20-46-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2023
CEFTRIAXONE 1G (VIAL)
05/10/2023
05/17/2023
IV
1.2gm
Q24
PCAP-B
Waiting Final Action 
05/12/2023
CEFUROXIME 750MG (VIAL)
05/12/2023
05/18/2023
IVT
500 Mg
Q8
Urti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: